⌘K

Login Start Free

Home/Filings/4/0001159036-15-000084

4//SEC Filing

HALOZYME THERAPEUTICS INC 4

Accession 0001159036-15-000084

$HALOCIK 0001159036operating

View on SEC.gov Company Profile

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 4:34 PM ET

Size

6.6 KB

Accession

0001159036-15-000084

Insider Transaction Report

Form 4

Period: 2015-08-28

HALOZYME THERAPEUTICS INCHALO

Kelley Kenneth J

Director

Transactions

Exercise/Conversion
Common Stock
2015-08-28$10.37/sh+10,000$103,700→ 208,051 total
Exercise/Conversion
Option to Purchase Common Stock
2015-08-28$10.37/sh−10,000$103,700→ 0 total
Exercise: $10.37From: 2008-05-15Exp: 2017-05-15→ Common Stock (10,000 underlying)

Documents

1 file

4
wf-form4_144113965400846.xmlPrimary
FORM 4

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001159036

Filing Metadata

Form type: 4
Filed: Aug 31, 8:00 PM ET
Accepted: Sep 1, 4:34 PM ET
Size: 6.6 KB

View on SEC.gov